Viewing StudyNCT00000821



Ignite Creation Date: 2024-05-05 @ 11:07 AM
Last Modification Date: 2024-10-26 @ 9:02 AM
Study NCT ID: NCT00000821
Status: COMPLETED
Last Update Posted: 2021-11-03
First Post: 1999-11-02

Brief Title: Subcutaneously Administered Aldesleukin Interleukin-2 IL-2 Therapy in HIV-Infected Patients
Sponsor: National Institute of Allergy and Infectious Diseases NIAID
Organization: National Institute of Allergy and Infectious Diseases NIAID

Key Dates - Follows AllAPIJSON File Order

Start Date: None
Start Date Type: None
Primary Completion Date: None
Primary Completion Date Type: None
Completion Date: 2002-03
Completion Date Type: ACTUAL
First Submit Date: 1999-11-02
First Submit QC Date: August 30 2001
Study First Post Date: 2001-08-31
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-10-27
Last Update Post Date: 2021-11-03
Last Update Post Date Type: ACTUAL